Trial Details

NOT_YET_RECRUITING
Basic Information
Clinical ID c1364
Identifier NCT06405087
Trial Title A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis|Crohn's Disease
Interventions DRUG: Vedolizumab SC|OTHER: No Intervention
Participant Information
Sponsor Takeda
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-07-11
Primary Completion Date 2032-01-26
Completion Date 2032-01-26